{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:04:15Z","timestamp":1783699455370,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["17-0596"],"award-info":[{"award-number":["17-0596"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","award":["20 1354 PjF"],"award-info":[{"award-number":["20 1354 PjF"]}],"id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2016-02974"],"award-info":[{"award-number":["2016-02974"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P50-CA92629"],"award-info":[{"award-number":["P50-CA92629"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","goldjournal.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.urology.2021.08.014","type":"journal-article","created":{"date-parts":[[2021,8,24]],"date-time":"2021-08-24T11:13:54Z","timestamp":1629803634000},"page":"102-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume"],"prefix":"10.1016","volume":"157","author":[{"given":"Emily A.","family":"Vertosick","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Zappala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanoj","family":"Punnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Hugosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen A.","family":"Boorjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Haese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1086-4334","authenticated-orcid":false,"given":"Peter","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bjartell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Lilja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2021.08.014_bib0001","doi-asserted-by":"crossref","first-page":"16031","DOI":"10.1038\/nrdp.2016.31","article-title":"Benign prostatic hyperplasia","volume":"2","author":"Chughtai","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.urology.2021.08.014_bib0002","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/j.ejca.2010.11.012","article-title":"Prediction of prostate cancer in unscreened men: external validation of a risk calculator","volume":"47","author":"van Vugt","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.urology.2021.08.014_bib0003","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/JU.0000000000001007","article-title":"Prespecified four kallikrein marker model (4Kscore) at age 50 or 60 for early detection of lethal prostate cancer in a large population-based cohort of asymptomatic men followed for 20 years","volume":"204","author":"Vertosick","year":"2020","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.08.014_bib0004","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.eururo.2018.02.016","article-title":"Twenty-year risk of prostate cancer death by midlife prostate-specific antigen and a panel of four kallikrein markers in a large population-based cohort of healthy men","volume":"73","author":"Sjoberg","year":"2018","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.08.014_bib0005","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1464-410X.2012.11690.x","article-title":"Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?","volume":"112","author":"Carlsson","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.08.014_bib0006","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1097\/RMR.0000000000000226","article-title":"Magnetic resonance imaging of prostate adenocarcinoma: detection and staging","volume":"29","author":"Ward","year":"2020","journal-title":"Top Magn Reson Imaging"},{"issue":"8 Pt 2","key":"10.1016\/j.urology.2021.08.014_bib0007","first-page":"E171","article-title":"Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detection","volume":"108","author":"Haffner","year":"2011","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.08.014_bib0008","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.eururo.2015.12.006","article-title":"Role of magnetic resonance imaging in prostate cancer screening: a pilot study within the goteborg randomised screening trial","volume":"70","author":"Grenabo Bergdahl","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.08.014_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1741-7015-6-19","article-title":"A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden","volume":"6","author":"Vickers","year":"2008","journal-title":"BMC Med"},{"key":"10.1016\/j.urology.2021.08.014_bib0010","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1200\/JCO.2009.24.1968","article-title":"Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication","volume":"28","author":"Vickers","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2021.08.014_bib0011","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/cncr.25010","article-title":"Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden","volume":"116","author":"Vickers","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2021.08.014_bib0012","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1158\/1078-0432.CCR-10-0122","article-title":"A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam","volume":"16","author":"Vickers","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2021.08.014_bib0013","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/sj.bjc.6605815","article-title":"A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands","volume":"103","author":"Gupta","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2021.08.014_bib0014","article-title":"Prospective validation of microseminoprotein-\u03b2 added to a four kallikrein panel in predicting high grade prostate cancer in an international multi-center academic cohort","author":"Lonergan","year":"2020","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2021.08.014_bib0015","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.eururo.2015.04.028","article-title":"A Four-kallikrein panel predicts high-grade cancer on biopsy: independent validation in a community cohort","volume":"69","author":"Braun","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.08.014_bib0016","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.eururo.2014.10.021","article-title":"A multi-institutional prospective trial in the USA confirms that the 4Kscore accurately identifies men with high-grade prostate cancer","volume":"68","author":"Parekh","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2021.08.014_bib0017","doi-asserted-by":"crossref","unstructured":"Punnen S, Freedland S, Polascik TJJU. A multi-institutional prospective trial in the Veterans Affairs Health System confirms the 4Kscore maintains its predictive value among African American men. 2018;199:1459-1463.","DOI":"10.1016\/j.juro.2017.11.113"},{"key":"10.1016\/j.urology.2021.08.014_bib0018","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1021\/ac061201+","article-title":"Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments","volume":"78","author":"V\u00e4is\u00e4nen","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/j.urology.2021.08.014_bib0019","doi-asserted-by":"crossref","first-page":"djv095","DOI":"10.1093\/jnci\/djv095","article-title":"Predicting high-grade cancer at ten-core prostate biopsy using four kallikrein markers measured in blood in the ProtecT study","volume":"107","author":"Bryant","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2021.08.014_bib0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2214\/AJR.07.3617","article-title":"Interobserver variability of transrectal ultrasound for prostate volume measurement according to volume and observer experience","volume":"192","author":"Choi","year":"2009","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.urology.2021.08.014_bib0021","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0022-5347(05)66091-0","article-title":"Interexaminer reliability of transrectal ultrasound for estimating prostate volume","volume":"166","author":"Sech","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2021.08.014_bib0022","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1159\/000508755","article-title":"Current role of multiparametric MRI and MRI targeted biopsies for prostate cancer diagnosis in germany: a nationwide survey","volume":"104","author":"Saar","year":"2020","journal-title":"Urol Int"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521007937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429521007937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T14:56:31Z","timestamp":1777474591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429521007937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":22,"alternative-id":["S0090429521007937"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2021.08.014","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Individual Patient Data Meta-analysis of Discrimination of the Four Kallikrein Panel Associated With the Inclusion of Prostate Volume","name":"articletitle","label":"Article Title"},{"value":"Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urology.2021.08.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}